These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 33406369)

  • 1. Persistent, Progressive Pulmonary Fibrosis and Epithelial Remodeling in Mice.
    Redente EF; Black BP; Backos DS; Bahadur AN; Humphries SM; Lynch DA; Tuder RM; Zemans RL; Riches DWH
    Am J Respir Cell Mol Biol; 2021 Jun; 64(6):669-676. PubMed ID: 33406369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repetitive intratracheal bleomycin models several features of idiopathic pulmonary fibrosis.
    Degryse AL; Tanjore H; Xu XC; Polosukhin VV; Jones BR; McMahon FB; Gleaves LA; Blackwell TS; Lawson WE
    Am J Physiol Lung Cell Mol Physiol; 2010 Oct; 299(4):L442-52. PubMed ID: 20562227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratracheal bleomycin causes airway remodeling and airflow obstruction in mice.
    Polosukhin VV; Degryse AL; Newcomb DC; Jones BR; Ware LB; Lee JW; Loyd JE; Blackwell TS; Lawson WE
    Exp Lung Res; 2012 Apr; 38(3):135-46. PubMed ID: 22394287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Micro-CT-assisted identification of the optimal time-window for antifibrotic treatment in a bleomycin mouse model of long-lasting pulmonary fibrosis.
    Buccardi M; Grandi A; Ferrini E; Buseghin D; Villetti G; Civelli M; Sverzellati N; Aliverti A; Pennati F; Stellari FF
    Sci Rep; 2024 Jun; 14(1):14792. PubMed ID: 38926490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Bleomycin Model of Pulmonary Fibrosis.
    Liu T; De Los Santos FG; Phan SH
    Methods Mol Biol; 2017; 1627():27-42. PubMed ID: 28836192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transmembrane protease, serine 4 (TMPRSS4) is upregulated in IPF lungs and increases the fibrotic response in bleomycin-induced lung injury.
    Valero-Jiménez A; Zúñiga J; Cisneros J; Becerril C; Salgado A; Checa M; Buendía-Roldán I; Mendoza-Milla C; Gaxiola M; Pardo A; Selman M
    PLoS One; 2018; 13(3):e0192963. PubMed ID: 29529050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen activator inhibitor-1 suppresses profibrotic responses in fibroblasts from fibrotic lungs.
    Marudamuthu AS; Shetty SK; Bhandary YP; Karandashova S; Thompson M; Sathish V; Florova G; Hogan TB; Pabelick CM; Prakash YS; Tsukasaki Y; Fu J; Ikebe M; Idell S; Shetty S
    J Biol Chem; 2015 Apr; 290(15):9428-41. PubMed ID: 25648892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A New Model of Acute Exacerbation of Experimental Pulmonary Fibrosis in Mice.
    Yegen CH; Haine L; Da Costa Ferreira K; Marchant D; Bernaudin JF; Planès C; Voituron N; Boncoeur E
    Cells; 2022 Oct; 11(21):. PubMed ID: 36359778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pathogenesis of bleomycin-induced lung injury in animals and its applicability to human idiopathic pulmonary fibrosis.
    Williamson JD; Sadofsky LR; Hart SP
    Exp Lung Res; 2015 Mar; 41(2):57-73. PubMed ID: 25514507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indocyanine-enhanced mouse model of bleomycin-induced lung fibrosis with hallmarks of progressive emphysema.
    Grandi A; Ferrini E; Mecozzi L; Ciccimarra R; Zoboli M; Leo L; Khalajzeyqami Z; Kleinjan A; Löwik CWGM; Donofrio G; Villetti G; Stellari FF
    Am J Physiol Lung Cell Mol Physiol; 2023 Feb; 324(2):L211-L227. PubMed ID: 36625471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of cultured human alveolar basal cells to mimic honeycomb formation in idiopathic pulmonary fibrosis.
    Blumer S; Khan P; Artysh N; Plappert L; Savic S; Knudsen L; Jonigk D; Kuehnel MP; Prasse A; Hostettler KE
    Respir Res; 2024 Jan; 25(1):26. PubMed ID: 38200596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alveolar epithelial TET2 is not involved in the development of bleomycin-induced pulmonary fibrosis.
    Qin W; Crestani B; Spek CA; Scicluna BP; van der Poll T; Duitman J
    FASEB J; 2021 May; 35(5):e21599. PubMed ID: 33913570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mimosa pudica L. extract ameliorates pulmonary fibrosis via modulation of MAPK signaling pathways and FOXO3 stabilization.
    Nguyen QC; Nguyen HA; Pham TA; Tran VT; Nguyen TD; Pham DV
    J Ethnopharmacol; 2024 Aug; 330():118226. PubMed ID: 38670401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine-like factor 1 gene expression is enriched in idiopathic pulmonary fibrosis and drives the accumulation of CD4+ T cells in murine lungs: evidence for an antifibrotic role in bleomycin injury.
    Kass DJ; Yu G; Loh KS; Savir A; Borczuk A; Kahloon R; Juan-Guardela B; Deiuliis G; Tedrow J; Choi J; Richards T; Kaminski N; Greenberg SM
    Am J Pathol; 2012 May; 180(5):1963-78. PubMed ID: 22429962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MUTYH Deficiency Is Associated with Attenuated Pulmonary Fibrosis in a Bleomycin-Induced Model.
    Sun Q; Chen J; Xu L; Kang J; Wu X; Ren Y; Nakabeppu Y; Wang Y
    Oxid Med Cell Longev; 2020; 2020():4828256. PubMed ID: 33149810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic Expression of a Clinical
    Rodriguez L; Tomer Y; Carson P; Dimopoulos T; Zhao M; Chavez K; Iyer S; Huang L; Ebert C; Sereda L; Murthy A; Trujillo G; Beers MF; Katzen J
    Am J Respir Cell Mol Biol; 2023 Apr; 68(4):358-365. PubMed ID: 36473455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptomic and proteomic profiling of young and old mice in the bleomycin model reveals high similarity.
    Klee S; Picart-Armada S; Wenger K; Birk G; Quast K; Veyel D; Rist W; Violet C; Luippold A; Haslinger C; Thomas M; Fernandez-Albert F; Kästle M
    Am J Physiol Lung Cell Mol Physiol; 2023 Mar; 324(3):L245-L258. PubMed ID: 36625483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of early metabolic response assessed by 18F-FDG PET/CT after initiation of antifibrotic drugs in IPF patients.
    Bondue B; Castiaux A; Van Simaeys G; Mathey C; Sherer F; Egrise D; Lacroix S; Huaux F; Doumont G; Goldman S
    Respir Res; 2019 Jan; 20(1):10. PubMed ID: 30646908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of ANT1 Increases Fibrosis and Epithelial Cell Senescence in Idiopathic Pulmonary Fibrosis.
    Sui J; Boatz JC; Shi J; Hu Q; Li X; Zhang Y; Königshoff M; Kliment CR
    Am J Respir Cell Mol Biol; 2023 Nov; 69(5):556-569. PubMed ID: 37487137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-326-mediated overexpression of NFIB offsets TGF-β induced epithelial to mesenchymal transition and reverses lung fibrosis.
    Pattnaik B; Negi V; Chaudhuri R; Desiraju K; Faizan MI; Akhtar A; Ansari MS; Shakir M; Gheware A; Prakash YS; Guleria R; Ghosh B; Agrawal A; Ahmad T
    Cell Mol Life Sci; 2023 Nov; 80(12):357. PubMed ID: 37950757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.